PCOSMar 15, 2026
If you have PCOS and feel like fat gravitates to your midsection no matter what you do, you're not imagining it. Research consistently shows that women with PCOS accumulate more abdominal fat than women without it, even when they weigh the same overall. This pattern has a name in online communities ("PCOS belly"), and while that's not a medical diagnosis, the science behind it is real and worth understanding.
PCOS belly isn't just a cosmetic concern. It's driven by a specific hormonal and metabolic loop involving insulin resistance and excess androgens, and it independently raises your risk for type 2 diabetes, metabolic syndrome, and cardiovascular disease. The good news is that targeted lifestyle changes (and, when needed, certain medications) can break that cycle.
TestosteroneMar 15, 2026
High dihydrotestosterone (DHT) levels are often blamed for prostate cancer, cardiovascular disease, and hair loss. But most research shows that high DHT is rarely dangerous for men. It can cause hair and skin changes and increase red blood cell production, but prostate and cardiovascular risks remain low. In women, however, elevated DHT can disrupt fertility and trigger PCOS-like symptoms.
PCOSMar 14, 2026
Metformin does real, measurable things for PCOS. It improves insulin resistance, nudges weight and cholesterol in the right direction, and helps regulate periods. But those benefits are modest across the board, and for the symptoms many people care about most, like excess hair growth, acne, and ovulation, it's not the strongest tool available. It's a solid supporting player, not a headliner.
That distinction matters because metformin is one of the most commonly prescribed medications for PCOS, used off-label to target the metabolic side of the condition. Understanding exactly where it pulls its weight, and where other options outperform it, is the difference between a treatment plan that works and one that leaves you frustrated.
Weight ManagementMar 14, 2026
Spironolactone does not cause clinically meaningful weight gain. Across every population studied, from heart failure patients to women with PCOS to obese postmenopausal women, the pattern is consistent: weight either stays the same or drops slightly. In one large cardiovascular trial with over 1,700 patients, spironolactone actually cut the odds of gaining significant weight nearly in half during the first year.
That's a notably clean signal for a medication many people worry about. If you've been prescribed spironolactone and Googled the side effects list, you may have seen "weight gain" mentioned. The clinical evidence tells a different story.
PCOSMar 13, 2026
Letrozole was designed to treat breast cancer. But in head-to-head comparisons against clomiphene, the drug that dominated fertility treatment for over 50 years, letrozole produced higher ovulation rates, higher pregnancy rates, and more live births in women with PCOS. That shift was significant enough for international guidelines to now recommend letrozole as the first-line medication for ovulation induction in PCOS.
What makes this especially notable is that letrozole isn't just more effective in key populations. It also tends to produce single-follicle ovulation rather than multiple follicles, which translates to fewer twins and triplets. For anyone weighing fertility treatment options, that combination of better outcomes with lower risk of multiples is worth understanding.
Cholesterol ManagementMar 13, 2026
Across multiple human studies, including randomized trials, long-term treatment data, and post-surgical follow-ups, atorvastatin does not appear to cause weight gain. That is not a hedged, "maybe-maybe-not" conclusion. It is a consistent finding that shows up in different patient populations, at different doses, and over different timeframes. If the number on your scale is climbing while you take atorvastatin, the research strongly suggests something else is responsible.
This matters because statins are among the most widely prescribed drugs in the world, and weight concerns are one of the reasons people consider stopping them. The evidence available gives a clear picture worth understanding.
PCOSMar 13, 2026
Polycystic ovary syndrome, or PCOS, sits at the crossroads of hormones and metabolism. It’s one of the most common endocrine disorders among women of reproductive age, affecting as many as one in ten globally. While it is often defined by irregular cycles, ovarian cysts, and elevated androgens, the underlying engine driving much of its dysfunction is metabolic. Many women with PCOS live with insulin resistance, dyslipidemia, and chronic low-grade inflammation. These conditions not only disrupt hormones but also raise long-term risks for diabetes and cardiovascular disease.
Doctors have long prescribed diet as the first-line therapy for managing PCOS, but the specifics remain contentious. Should women cut carbohydrates, go Mediterranean, or count calories? The research over the past decade has moved beyond simplistic “low-fat versus low-carb” debates to ask a more nuanced question: what kind of eating pattern best improves metabolic health when the body’s insulin signaling is out of sync?
